TITLE

Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications

AUTHOR(S)
Athmaram, T.; Saraswat, Shweta; Misra, Princi; Shrivastava, Saurabh; Singh, Anil; Verma, Shailendra; Gopalan, N.; Behara, Prativa; Rao, P.
PUB. DATE
April 2013
SOURCE
Virus Genes;Apr2013, Vol. 46 Issue 2, p219
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Dengue non-structural protein (NS1) is known to be protective antigen and also has immense application for serodiagnosis. Several serodiagnostic assays available for dengue viral infection are dependent on tissue culture-grown viral proteins. This task is unsafe, laborious, more expensive that makes it unsuitable for routine large-scale production. Although bacterial expression is relatively simple and easy for recombinant protein expression, it is more challenging to make NS1 protein with native structural and immunological features using bacterial expression system. We have successfully developed a method leading to the purification and refolding of recombinant dengue virus type 3 (DENV3) NS1. The gene encoding NS1 was amplified and cloned in pET28a (+) vector. In order to increase the purity of the recombinant NS1, the transgene was engineered to carry 6× Histidine tags at both N and C-terminal ends. The recombinant construct (pETNS1) was transformed into E. coli Rosetta-gami cells and the expression conditions viz IPTG concentration, media type, temperature, and harvest time were optimized. The size of the expressed protein was found to be ~45 kDa and the authenticity of the expressed protein was confirmed using anti-His and anti-NS1 monoclonal antibodies. The NS1 protein was purified under denaturing conditions, to attain the native conformation, NS1 protein was in vitro refolded and dialyzed. The refolded NS1 protein was detected by commercial Immuno chromatographic strip and NS1 specific monoclonal antibodies. IgM antibody capture ELISA was performed using refolded recombinant NS1 protein which recognized the IgM antibodies in dengue-positive samples of acute phase of infection. Our result suggests that rNS1 protein has immense diagnostic potential and can be used in developing point of care diagnostic assays.
ACCESSION #
86406647

 

Related Articles

  • Passive Protection Assay of Monoclonal Antibodies Against Dengue Virus in Suckling Mice. Zongtao Chen; Li-Mei Liu; Na Gao; Xiao-Feng Xu; Jun-Lei Zhang; Jia-Li Wang; Jing An // Current Microbiology;Apr2009, Vol. 58 Issue 4, p326 

    Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are highly infectious diseases caused by dengue virus (DV). Specific monoclonal antibodies (mAbs) against DV are vital for diagnosis, pathological studies, and passive immune therapy. In this study, purified DV serotype 2 (DV2) was...

  • Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody. Tian, Yanping; Chen, Wei; Yang, Ya; Xu, Xiaofeng; Zhang, Junlei; Wang, Jiali; Xiao, Lan; Chen, Zongtao // Applied Microbiology & Biotechnology;Feb2013, Vol. 97 Issue 4, p1553 

    Dengue virus is a major international public health concern, and there is a lack of available effective vaccines. Virus-specific epitopes could help in developing epitope peptide vaccine. Previously, a neutralizing monoclonal antibody (mAb) 4F5 against nonstructural protein 3 (NS3) of dengue...

  • Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes. Li, Leike; Meng, Weixu; Horton, Melanie; DiStefano, Daniel R.; Thoryk, Elizabeth A.; Pfaff, Jennifer M.; Wang, Qihui; Salazar, Georgina T.; Barnes, Trevor; Doranz, Benjamin J.; Bett, Andrew J.; Casimiro, Danilo R.; Vora, Kalpit A.; An, Zhiqiang; Zhang, Ningyan // PLoS Pathogens;6/6/2019, Vol. 15 Issue 6, p1 

    There is still no safe and effective vaccine against dengue virus infection. Epidemics of dengue virus infection are increasingly a threat to human health around the world. Antibodies generated in response to dengue infection have been shown to impact disease development and effectiveness of...

  • A High-Throughput, Precipitating Colorimetric Sandwich ELISA Microarray for Shiga Toxins. Gehring, Andrew; Xiaohua He; Fratamico, Pina; Lee, Joseph; Bagi, Lori; Brewster, Jeffrey; Paoli, George; Yiping He; Yanping Xie; Skinner, Craig; Barnett, Charlie; Harris, Douglas // Toxins;Jun2014, Vol. 6 Issue 6, p1855 

    Shiga toxins 1 and 2 (Stx1 and Stx2) from Shiga toxin-producing E. coli (STEC) bacteria were simultaneously detected with a newly developed, high-throughput antibody microarray platform. The proteinaceous toxins were immobilized and sandwiched between biorecognition elements (monoclonal...

  • Identification of Binding Epitope for Anti-Rabies Virus Glycoprotein Single-Chain Fv Fragment FV57. Tie-jun Gu; Wei Wei; Ye Duan; Chun-lai Jiang; Yan Chen; Xiang-hui Yu; Jia-xin Wu; Yong-ge Wu; Wei Kong // Protein & Peptide Letters;Nov2011, Vol. 18 Issue 11, p1099 

    Single-chain Fv fragment (scFv) of anti-rabies glycoprotein (G protein) has been recommended as a new agent for detecting and neutralizing lethal rabies virus. In this study, we constructed scFv that corresponded to the FV fragment of CR57, a monoclonal antibody against rabies virus, and called...

  • A novel enzyme-linked immunosorbent assay for detection of Escherichia coli O157:H7 using immunomagnetic and beacon gold nanoparticles. Zhiqiang Shen; Nannan Hou; Min Jin; Zhigang Qiu; Jingfeng Wang; Bin Zhang; Xinwei Wang; Jie Wang; Dongsheng Zhou; Junwen Li // Gut Pathogens;2014, Vol. 6 Issue 1, p1 

    This paper presents a functional nanoparticle-enhanced enzyme-linked immunosorbent assay (FNP-ELISA) for detection of enterohemorrhagic Escherichia coli (EHEC) O157:H7. Immunomagnetic nanoparticles (IMMPs) conjugated with monoclonal anti-O157:H7 antibody were used to capture E. coli O157:H7....

  • EVALUATION OF A MONOCLONAL ANTIBODIES PANEL DIRECTED AGAINST FIMBRIAL ANTIGENS K88, K99, F41 AND 987P OF ENTEROTOXIGENIC ESCHERICHIA COLI. Junco, J.; Campal, A.; Miranda, A.; Castro, M.; Arteaga, N.; Casas, S.; León, L.; Alvarez, T.; Sanchez, D.; Fernández, G.; Fontirroche, G. // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Enterotoxigenic Escherichia coli (ETEC) represents a large group of strains bacteria that are toxigenic to small intestine of neonates in a number of species including pigs, cattle, sheep, and humans. It well established that the ability of ETEC to colonize the intestine is due to fimbrial...

  • Development of a sandwich ELISA for the detection of Listeria spp. using specific flagella antibodies. Seong-Hee Kim; Min-Keun Park; Jin-Young Kim; Pham Duc Chuong; Yong-Soon Lee; Byoung-Su Yoon; Kyu-Kye Hwang; Yoon- Kyu Lim // Journal of Veterinary Science;2006, Vol. 7 Issue 1, p41 

    Five monoclonal antibodies (MAbs) and chicken immunoglobulin (IgY) were developed by immunizing with flagella purified from Listeria monocytogenes 4b and the five MAbs have been confirmed to be specific against three different epitopes of flagellin. The antibodies showed specific reaction to...

  • Functional expression, characterization and application of the human S100A4 protein. DEGANG WANG; JIANWEI ZHANG; ZIQUAN LIU; YUNYUN CHEN; CHUANXIANG XU; ZHIQING ZHANG; XIAOHUA LIU; LEI WU; XUESI ZHOU; XIANGYAN MENG; HUA LI; HONGTAO LIU; ZIFENG JIANG; TIANHUI WANG // Molecular Medicine Reports;2015, Vol. 11 Issue 1, p175 

    Preparations utilizing monoclonal antibodies against S100A4 provide useful tools for functional studies to investigate the clinical applications of the human S100A4 protein. In the present study, human S100A4 protein was expressed in Escherichia coli (E. coli) BL21 (DE3), successfully purified...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics